# Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery

> **NCT00006470** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group**

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** monoclonal antibody 11D10 anti-idiotype vaccine
- **BIOLOGICAL:** monoclonal antibody 3H1 anti-idiotype vaccine
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00006470
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2004-12
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006470, "Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00006470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*